3.44
0.11 (3.3%)
0.11 (3.3%)
Upgrade to Real-Time
Regular Market
Low
2.09
High
13.78
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Akebia Therapeutics Inc | AKBA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.11 | 3.3% | 3.44 | 14:26:53 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.32 | 3.31 | 3.45 | 3.33 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 3.44 | 3.45 | 0.01 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,277 | 1,805,989 | $ 3.39 | $ 6,117,770 | 3,311,167 | 2.09 - 13.78 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:27:30 | 47 | $ 3.45 | USD |
Akebia Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 550.80M | 160.12M | 136.06M | $ 295.31M | $ - | -2.76 | -1.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 1.59M | 2.00% |
Akebia Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AKBA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.04 | 3.465 | 2.75 | 3.16 | 3,549,404 | 0.40 | 13.16% |
| 1 Month | 3.03 | 3.465 | 2.74 | 3.08 | 3,208,597 | 0.41 | 13.53% |
| 3 Months | 4.37 | 4.52 | 2.74 | 3.39 | 4,483,401 | -0.93 | -21.28% |
| 6 Months | 2.56 | 5.14 | 2.52 | 3.44 | 5,446,513 | 0.88 | 34.38% |
| 1 Year | 11.56 | 13.78 | 2.09 | 3.83 | 4,976,308 | -8.12 | -70.24% |
| 3 Years | 9.92 | 13.78 | 2.09 | 4.78 | 2,363,900 | -6.48 | -65.32% |
| 5 Years | 7.77 | 20.25 | 2.09 | 5.53 | 1,575,718 | -4.33 | -55.73% |
Akebia Therapeutics Description
| Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product for the treatment of anemia. Geographically, all the business activity is functioned through the region of United States. |
